XML 98 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
RESTATEMENTS AND REVISIONS
3 Months Ended
Mar. 31, 2014
RESTATEMENTS AND REVISIONS

Note 3—RESTATEMENTS AND REVISIONS:

As disclosed in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2013 as filed with the SEC on November 12, 2013, the Company revised its Condensed Consolidated Financial Statements for the three months ended March 31, 2013 for computational errors in the calculation of revenues and cost of sales on contracts requiring the application of the percentage-of-completion revenue recognition methodology under ASC 605-35 and opening balance sheet corrections related to deferred taxes and goodwill associated with its acquisition of RTI Remmele Engineering. In the Annual Report, the Company subsequently restated its Condensed Consolidated Financial Statements for the three months ended March 31, 2013 to establish a full valuation allowance against its Canadian net deferred tax asset, and correct the related provision for income taxes. The following tables set forth the impact of the revision and restatement, as well as adjustments for the presentation of RTI Connecticut as a discontinued operation, on the Condensed Consolidated Statement of Operations and the Condensed Consolidated Statement of Cash Flows as filed in the Company’s Amended Quarterly Report on Form 10-Q/A for the period ended March 31, 2013 as filed with the SEC on September 24, 2013.

 

Condensed Consolidated Statement of Operations:

 

    Three Months Ended March 31, 2013  
    Previously
Reported (1)
    Revision
Adjustment (2)
    As
Revised
    Restatement
Adjustment
    As
Corrected
    Discontinued
Operations
    Currently
Reported
 

Net sales

  $ 191,900      $ (662   $ 191,238      $ —        $ 191,238      $ (2,036   $ 189,202   

Cost and expenses:

             

Cost of sales

    151,986        (26     151,960        —          151,960        (2,011     149,949   

Selling, general, and administrative expenses

    24,908        —          24,908        —          24,908        (303     24,605   

Research, technical, and product development expenses

    1,001        —          1,001        —          1,001        —          1,001   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

    14,005        (636     13,369        —          13,369        278        13,647   

Other income, net

    559        —          559        —          559        —          559   

Interest income

    31        —          31        —          31        —          31   

Interest expense

    (4,796     —          (4,796     —          (4,796     —          (4,796
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income before income taxes

    9,799        (636     9,163        —          9,163        278        9,441   

Provision for income taxes

    2,982        (178     2,804        1,625        4,429        44        4,473   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributable to continuing operations

    6,817        (458     6,359        (1,625     4,734        234        4,968   

Net income (loss) attributable to discontinued operations, net of tax

    151        —          151        —          151        (234     (83
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

  $ 6,968      $ (458   $ 6,510      $ (1,625   $ 4,885      $ —        $ 4,885   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Earnings per share attributable to continuing operations:

             

Basic

  $ 0.22      $ (0.02   $ 0.21      $ (0.05   $ 0.16      $ 0.01      $ 0.16   

Diluted

  $ 0.22      $ (0.02   $ 0.21      $ (0.05   $ 0.15      $ 0.01      $ 0.16   

Earnings per share attributable to discontinued operations:

             

Basic

  $ —        $ —        $ —        $ —        $ —        $ (0.01   $ —     

Diluted

  $ —        $ —        $ —        $ —        $ —        $ (0.01   $ —     

 

(1): Previously reported balances represent the amounts reported in the Condensed Consolidated Statement of Operations in the Company’s Amended Quarterly Report on Form 10-Q/A for the quarterly period ended March 31, 2013 as filed with the SEC on September 24, 2013.
(2): Amounts presented as Revision Adjustment represent revisions for revenue recognition errors related to certain long-term projects as disclosed in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2013 as filed with the SEC on November 12, 2013.

 

Condensed Consolidated Statement of Cash Flows:

 

     March 31, 2013  
     Previously
Reported (1)
    Revision
Adjustment (2)
    Restatement
Adjustment
    Currently
Reported
 

OPERATING ACTIVITIES:

        

Net income

   $ 6,968      $ (458   $ (1,625   $ 4,885   

Adjustment for non-cash items included in net income:

        

Depreciation and amortization

     11,000        —          —          11,000   

Asset and asset-related charges (income)

     —          —          —          —     

Goodwill impairments

     484        —          —          484   

Deferred income taxes

     3,350        (178     1,625        4,797   

Stock-based compensation

     1,708        —          —          1,708   

Excess tax benefits from stock-based compensation activity

     (236     —          —          (236

(Gain) loss on sale of property, plant and equipment

     —          —          —          —     

Amortization of discount on long-term debt

     2,562        —          —          2,562   

Amortization of deferred financing costs

     325        —          —          325   

Other

     (41     —          —          (41

Changes in assets and liabilities:

        

Receivables

     (9,994     —          —          (9,994

Inventories

     (26,091     111        —          (25,980

Accounts payable

     (6,583     —          —          (6,583

Income taxes payable

     416        —          —          416   

Unearned revenue

     (5,194     532        —          (4,662

Cost in excess of billings

     (12     (7     —          (19

Liability for pension benefits

     —          —          —          —     

Other current assets and liabilities

     (10,520     —          104        (10,416

Other assets and liabilities

     1,135        —          (104     1,031   
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash provided by (used in) operating activities

     (30,723     —          —          (30,723

INVESTING ACTIVITIES:

        

Acquisitions, net of cash required

     —          —          —          —     

Maturity/sale of investments

     —          —          —          —     

Capital expenditures

     (9,160     —          —          (9,160

Purchase of investments

     —          —          —          —     

Proceeds from disposal of property, plant, and equipment

     —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash provided by (used in) investing activities

     (9,160     —          —          (9,160

FINANCING ACTIVITIES:

        

Proceeds from exercise of employee stock options

     1,239        —          —          1,239   

Excess tax benefits from stock-based compensation activity

     236        —          —          236   

Purchase of common stock held in treasury

     (399     —          —          (399

Repayments on long-term debt

     (220     —          —          (220
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash provided by (used in) financing activities

     856        —          —          856   

Effect of exchange rate changes on cash and cash equivalents

     (148     —          —          (148
  

 

 

   

 

 

   

 

 

   

 

 

 

Decrease in cash and cash equivalents

     (39,175     —          —          (39,175

Cash and cash equivalents at beginning of period

     97,190        —          —          97,190   
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 58,015      $ —        $ —        $ 58,015   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(1): Previously reported balances represent the amounts reported in the Condensed Consolidated Statement of Cash Flows in the Company’s Amended Quarterly Report on Form 10-Q/A for the quarterly period ended March 31, 2013 as filed with the SEC on September 24, 2013. The previously reported changes in inventory, cost in excess of billings, and deferred revenue have been adjusted by $1,040, $(174), and $(866) to correct the prior presentation.
(2): Amounts presented as Revision Adjustment represent revisions related to revenue recognition errors related to certain long-term projects, as well as adjustments to goodwill and deferred taxes related to the acquisition of Remmele in 2012, as disclosed in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2013 as filed with the SEC on November 12, 2013.